Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
International Journal of Cardiology|October 14, 2018
ACE2 and ACE in acute and chronic rejection after human heart transplantationMaria Jose Soler, Montserrat Batlle, Marta Riera, et al.
Oncotargets and Therapy|December 6, 2021
Durable Response to Vemurafenib and Cobimetinib for the Treatment of BRAF-Mutated Metastatic Melanoma in Routine Clinical PracticeMª Del Carmen Álamo, Sebastian Ochenduszko, Guillermo Crespo, et al.
Lung Cancer (Amsterdam, Netherlands)|August 9, 2023
Pembrolizumab as first-line treatment for advanced NSCLC in older adults: A phase II clinical trial evaluating geriatric and quality-of-life outcomesRemei Blanco, Manuel Dómine, José Luis González, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|October 6, 2012
Analysis of the arrhythmogenic substrate in human heart failureSara Partemi, Montserrat Batlle, Paola Berne, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 6, 2024
Identification of non-actionable mutations with prognostic and predictive value in patients with advanced or metastatic non-small cell lung cancerMariano Provencio-Pulla, Diego Pérez-Parente, Sara Olson, et al.
Journal of Personalized Medicine|March 29, 2023
Prognostic Value of Soluble AXL in Serum from Heart Failure Patients with Preserved and Reduced Left Ventricular Ejection FractionHelena Cristóbal, Cristina Enjuanes, Montserrat Batlle, et al.
Anti-Cancer Drugs|October 13, 2010
Molecular basis of hypertension side effects induced by sunitinibGuadalupe Aparicio-Gallego, Francisco J Afonso-Afonso, Luis León-Mateos, et al.
Journal of Clinical Medicine|October 13, 2021
PD-L1 Inhibitors as Monotherapy for the First-Line Treatment of Non-Small-Cell Lung Cancer in PD-L1 Positive Patients: A Safety Data Network Meta-AnalysisMaría Rosario García Campelo, Edurne Arriola, Begoña Campos Balea, et al.
Frontiers in Oncology|March 11, 2026
Clinical outcomes and survival in patients with NSCLC and EGFR exon 20 mutations: evidence from real-world clinical practice in a retrospective study in GaliciaBegoña Campos Balea, Martín Emilio Lázaro Quintela, Ma Carmen Areses Manrique, et al.
Pageof 6